30 Years of Evidence
Featured Content
Radiosurgery society
Frameless Radiosurgery is a Safe and Effective Treatment for Medically-Refractory Trigeminal Neuralgia in Elderly Patients
Radiosurgery society
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Radiosurgery society
Long-Term Outcomes of Vestibular Schwannoma Treated with Stereotactic Radiosurgery: A Retrospective Study from a Single Institution
Technical Note: Patient dose from kilovoltage radiographs during motion-synchronized treatments on Radixact®
Ferris WS, Culberson WS | Med Phys | 2020
Evaluation of radixact motion synchrony for 3D respiratory motion: Modeling accuracy and dosimetric fidelity
Ferris WS, Kissick MW, Bayouth JE, Culberson WS, Smilowitz JB | J Appl Clin Med Phys | 2020
Technical Note: Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws
Chen GP, Tai A, Keiper TD, Lim S, Li XA | Med Phys | 2020
Compensation of intrafractional motion for lung stereotactic body radiotherapy (SBRT) on helical TomoTherapy
Price A, Chen J, Chao E, Schnarr E, Schreiber E, Lu L, Cox A, Chang S, Jian J. | Biomed. Phys. Eng. Express | 2019
Feasibility of real-time motion management with helical tomotherapy
Schnarr E, Beneke M, Casey D, Chao E, Chappelow J, Cox A, Henderson D, Jordan P, Lessard E, Lucas D, Myronenko A, Mauer C | Med Phys | 2018
Evaluation of TomoTherapy dose calculations with intrafractional motion and motion compensation
Chao EH, Lucas D, Schnarr E | Med Phys | 2018
Characterization of imaging performance of a novel helical kVCT for use in image-guided and adaptive radiotherapy – PubMed (nih.gov)
Tegtmeier RC, Ferris WS, Bayouth JE, Miller JR, and Culberson WS | J Appl Clin Med Phys | 2022
Feasibility of image-guided robotic radiotherapy using three fractions for uveal melanoma
Choi SY, Kim MS, Yoo SY, Cho CK, Lhee CH, Lee DH, Kang JK, Shin YJ | Tumori | 2009
Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma
Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, Mocan BO, Zorlu F | Int J Radiat Oncol Biol Phys | 2017
Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy
Siedlecki J, Reiterer V, Leicht S, Foerster P, Kortüm K, Schaller U, Priglinger S, Fuerweger C, Muacevic A, Eibl-Lindner K | Acta Ophthalmol | 2017
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
Schmelter V, Heidorn S, Muacevic A, Priglinger SG, Foerster P, Liegl R | Melanoma Res | 2021
Robotic CyberKnife radiosurgery for small choroidal melanomas – PubMed (nih.gov)
Valerie Schmelter, Theresa Hofmann, Frederick Schneider, Constance Weber, Christoph Fuerweger, Alexander Muacevic, Siegfried G Priglinger, Paul Foerster, Raffael Liegl | Melanoma Res | 2022
Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT | Front Oncol | 2012
Stereotactic radiosurgery for metastasis to the craniovertebral junction preserves spine stability and offers symptomatic relief
Azad TD, Esparza R, Chaudhary N, Chang SD | Neurosurg Spine | 2016
Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases
Mehta N, Zavitsanos PJ, Moldovan K, Oyelese A, Fridley JS, Gokaslan Z, Kinsella TJ, Hepel JT | Adv Radiat Oncol | 2018
Radiation-Related Late Toxicities Following Total Marrow Irradiation Transplant Conditioning Regimens
Colton Ladbury et al. | ASTRO 2024
Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nisha Bhargava et al. | ASTRO 2024
Obliteration Rates for High-Risk Arteriovenous Malformations with Dose-Escalated Hypofractionated Radiosurgery
Sophia Shah et al. |ASTRO 2024
Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
Jeffrey Wong et al. | ASTRO 2024